Inventaire - els teus amics i comunitats són la teva millor biblioteca

Medication dosing for heart failure with reduced ejection fraction - opportunities and challenges

autor

Ali Ahmed

Gregg C. Fonarow

Clyde Yancy

1958 -

publicat a: European Journal of Heart Failure

date of publication: 2018-12-10

tema principal: heart failure with reduced ejection fraction, fracció d'ejecció

Cites articles 68

Date

Títol

Autors

2017-04-28

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society o

Javed Butler, Gregg C. Fonarow, Clyde Yancy, Frederick Masoudi
2017-11-20

Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.

Christian Torp-Pedersen, Mikkel Porsborg Andersen, Maurizio Sessa, Gunnar Hilmar Gislason, Rikke Nørmark Mortensen
2017-09-26

Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.

Aldo P. Maggioni, Alexandre Mebazaa, Luigi Tavazzi, Mitja Lainscak, Ewa Straburzyńska-Migaj, Jarosław Drożdż
2017-12-14

NT-proBNP-Guided Therapy in Acute Decompensated Heart Failure: The PRIMA II Randomized Controlled Trial.

João Pedro Ferreira, Jan G. P. Tijssen
2017-08-01

Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial

Daniel B. Mark, Kevin J Anstrom, James Januzzi, Christopher M O'Connor, Gary Felker, Nancy Houston Miller, Ileana L Piña, Justin Ezekowitz, Kirkwood F Adams, Eric S Leifer, Patrice Desvigne-Nickens, David J Whellan, Gayle Passmore
2017-05-25

Integrating electronic health records into the study of heart failure: promises and pitfalls

Marco Metra
2017-05-01

Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement?

Karl Swedberg
2017-12-13

2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus De

Javed Butler, James Januzzi, Clyde Yancy, Frederick Masoudi, Gregg C. Fonarow
2017-04-25

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society o

Javed Butler, Clyde Yancy, Frederick Masoudi, Gregg C. Fonarow
2016-06-10

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial

Michael R Zile, John McMurray, John R Teerlink, Jean Rouleau
2016-11-14

Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial

Karl Swedberg, John McMurray, Jean Rouleau, Victor C Shi, Michael R Zile, Milton Packer, Brian Claggett, Orly Vardeny
2016-04-20

Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey

Luigi Tavazzi, Michel Komajda, Piotr Ponikowski, Stefan D. Anker, Gerasimos Filippatos, Martin Cowie, QUALIFY Investigators
2016-12-01

Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.

Michael R Zile, John McMurray, Jean Rouleau
2016-11-01

Exploring New Endpoints for Patients With Heart Failure With Preserved Ejection Fraction

Mihai Gheorghiade, Bertram Pitt, Javed Butler, Stefan D. Anker, Clyde Yancy, Michael R Zile, Lothar Roessig, Sanjiv J Shah, Preston Dunnmon, Giuseppe Rosano, Norman Stockbridge, Wilfried Dinh, James E Udelson, Michele Senni, Carine E Hamo, Harold S Bernstein, Christophe Depre, Patricia Kay-Mugford, Afshin Salsali
2015-10-23

Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial

Christopher M O'Connor, Ileana L Piña
2014-09-11

Angiotensin-neprilysin inhibition versus enalapril in heart failure

Karl Swedberg, John McMurray, Jean Rouleau, Victor C Shi, Michael R Zile, Milton Packer, Adel R Rizkala
2014-05-08

Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist

Inder S Anand
2013-08-21

Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction

Javed Butler, Gregg C. Fonarow, Clyde Yancy, Deepak L. Bhatt, Adrian F. Hernandez, Harsh B Golwala
2012-03-01

Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy

Thomas Dieterle
2011-05-01

Hydralazine and isosorbide dinitrate in heart failure: historical perspective, mechanisms, and future directions

Mihai Gheorghiade, Javed Butler, Clyde Yancy, Arshed A Quyyumi
2011-09-19

Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF.

Mandeep R. Mehra, Gregg C. Fonarow, Mihai Gheorghiade, Christopher M O'Connor, Clyde Yancy, Nancy M Albert, Mark J McBride, Mary Norine Walsh, Patches Johnson Inge
2011-05-06

Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.

Christian Funck-Brentano, Dirk J van Veldhuisen
2010-07-15

Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.

Mandeep R. Mehra, Gregg C. Fonarow, Mihai Gheorghiade, Christopher M O'Connor, Clyde Yancy, Nancy M Albert, Mark J McBride, Mary Norine Walsh, Patches Johnson Inge
2010-11-14

Eplerenone in patients with systolic heart failure and mild symptoms

Faiez Zannad, Bertram Pitt, Karl Swedberg, Henry Krum, Dirk J van Veldhuisen, John McMurray, Harry Shi, EMPHASIS-HF Study Group
2010-01-01

Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF).

Gregg C. Fonarow, Mandeep R. Mehra, Mihai Gheorghiade, Christopher M O'Connor, Clyde Yancy, Wendy Gattis Stough, Nancy M Albert, Mark J McBride, Mary Norine Walsh
2010-09-01

Ivabradine in heart failure--no paradigm SHIFT…yet

John R Teerlink
2009-11-16

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

Kenneth Dickstein, Michel Komajda
2009-04-01

Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial

Faiez Zannad, Christopher M O'Connor, William E. Kraus, James A. Blumenthal, Nancy Houston Miller, Ileana L Piña, Eric S Leifer, Jerome L Fleg, David J Whellan, HF-ACTION Investigators, Dalane W Kitzman, Kevin Schulman
2009-11-01

The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications

Javed Butler
2008-09-01

Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)

Inder S Anand, Laura Angelici
2007-04-30

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure

Gregg C. Fonarow
2006-02-01

Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.

Donald Lloyd-Jones, James Januzzi, Carlos A. Camargo

Article - wd:Q90404983

Welcome to Inventaire

la biblioteca dels teus amics i comunitats

saber més